文献速递病毒性肝炎

急性丙型肝炎早期DAA治疗虽部分正常化可溶性炎症介质但遗留持久印记

Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C.
PubMed 文献 · J Infect Dis · 2022-01-01

该研究利用急性症状性丙型肝炎患者队列,经6周ledipasvir/sofosbuvir治疗清除HCV后,用邻位延伸分析检测血浆92种蛋白。急性HCV感染时可溶性炎症介质显著改变,早期DAA治疗使多数介质下降但未全部正常化,部分持续抑制或降低,提示HCV遗留持久印记。

要点

  • 急性HCV感染导致可溶性炎症介质显著改变,如IL-6和CXCL-10上调。
  • 6周ledipasvir/sofosbuvir治疗清除HCV后多数介质下降但未全部正常化。
  • 部分介质治疗前下调者持续抑制,初始无变化者随访中降低。

核心结论

  • 急性丙型肝炎与可溶性炎症介质显著改变相关,早期DAA治疗部分正常化但遗留持久印记。

研究设计与样本

  • 研究利用急性症状性丙型肝炎患者队列,经6周ledipasvir/sofosbuvir治疗清除HCV后,用邻位延伸分析检测血浆92种蛋白。

主要发现

  • 急性HCV患者可溶性炎症介质显著改变,IL-6和CXCL-10明显上调,单核细胞趋化蛋白-4和IL-7等下调。
  • 治疗和随访期间多数介质下降但未全部正常化,如CDCP1和IL-18。
  • 治疗前下调的介质持续抑制,初始无变化者如CD244在治疗和随访中降至更低值。

临床怎么用

  • 急性HCV感染早期DAA治疗虽可清除病毒,但可溶性炎症介质未完全正常化,需关注长期炎症印记。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment with direct-acting antivirals (DAAs) in patients with chronic hepatitis C infection leads to partial restoration of soluble inflammatory mediators (SIMs). In contrast, we hypothesized that early DAA treatment of acute hepatitis C virus (HCV) with DAAs may normalize most SIMs. METHODS: In this study, we made use of a unique cohort of acute symptomatic hepatitis C patients who cleared HCV with a 6-week course of ledipasvir/sofosbuvir. Plasma samples were used for proximity extension assay measuring 92 proteins. RESULTS: Profound SIM alterations were observed in acute HCV patients, with marked upregulation of interleukin (IL)-6 and CXCL-10, whereas certain mediators were downregulated (eg, monocyte chemoattractant protein-4, IL-7). During treatment and follow-up, the majority of SIMs decreased but not all normalized (eg, CDCP1, IL-18). Of note, SIMs that were downregulated before DAA treatment remained suppressed, whereas others that were initially unchanged declined to lower values during treatment and follow-up (eg, CD244). CONCLUSIONS: Acute hepatitis C was associated with marked changes in the soluble inflammatory milieu compared with both chronic hepatitis patients and healthy controls. Whereas early DAA treatment partly normalized this altered signature, long-lasting imprints of HCV remained.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Khera T, Du Y, Todt D, et al. Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C. J Infect Dis. 2022. PMID: 33517457. doi:10.1093/infdis/jiab048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。